No Data
Weak, weighed down by factors such as high long-term US interest rates.
[Emerging markets individual stock strategy] Today's emerging markets are expected to show a soft tone. In the U.S. stock market yesterday on the 28th, the Dow average rebounded by 273.17 points (+0.65%) to 42,387.57, rising for the first time in 6 days. Concerns about the escalation of the situation in the Middle East eased with Israel's limited retaliatory attack against Iran, and expectations for strong earnings from major companies such as high tech scheduled for this week supported stock prices. On the other hand, the rise in long-term interest rates became a concern, but the market remained strong throughout the day.
Medrek, Replcell, and others
Dream Vision's 11th subscription rights (with exercise price adjustment clause) will issue a large amount of shares starting from the 28th, with 0.5 million shares. MedRx MRX-7MLL <4586> has started clinical trials. OncoLis Bio's 20th subscription rights (with exercise price adjustment clause) will issue a large amount of shares starting from the 18th, with 0.512 million shares. Progress of clinical phases 1/2 trials for DELTA-PDF-10917 and VEN <4598>. Modalis's 14th subscription rights.
The Tokyo Stock Exchange Gross Market 250 Index significantly continued to decline, with little trading interest towards Metro businesses.
Tokyo Stock Exchange Growth Market Index 774.85 -12.83 / Volume 0.1 billion 53.45 million shares / Trading value 83.9 billion yen Tokyo Stock Exchange Growth Market 250 Index 604.09 -10.81 / Volume 86.73 million shares / Trading value 59.3 billion yen Today's Growth Market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, continued to decline significantly. The number of advancing stocks is 113, declining stocks is 437, unchanged is 36. The U.S. stock market on the 22nd had mixed performance. The Dow Jones Industrial Average fell by 6.71 dollars.
DWTI, Karada Note, and others.
<4014> Karada Note formulated a medium-term management plan for the period from July 25th to July 28th in 2028, with an operating profit target of over 1.5 billion yen for the fiscal year ending July 28th, 2028. <4576> DWI Tokyo University has signed a joint research contract for the purpose of researching and developing a new treatment drug related to glaucoma surgery. <4588> Oncolyse Bio has announced a large exercise of the 20th subscription rights (with price adjustment provisions) starting on the 16th, issuing 0.4 million shares. <6561> HANATOUR will be closing its branches.
NPC, Double A, and others [Emerging Markets Press Release]
<2936> BaseFood, a Ministry of Agriculture, Forestry and Fisheries project selected for the 'Small and Medium Enterprise Innovation Creation Promotion Project', revises its performance forecast. The current fiscal year's operating profit outlook is 5.1 billion yen, down from 16.6 billion yen. <3990> UUM revises its performance forecast, with the previous operating profit outlook at 33 billion yen now expected to be between 4.5 to 0.57 billion yen. <4055> Tier and S G Software Exstage, which is involved in planning software and computer systems, has signed a basic agreement towards acquiring shares (subsidiarization). <4260> Hybrid Tech subsidiary.
Lion and other stocks with attractive characteristics based on volume changes.
Stock Closing Price Day before Volume* ＜9563＞Atlas 365 80 1477300 ＜7074＞247 183 3 1089300 ＜4416＞TrueData 415 28 98500 ＜184A＞Learning Aid 790 100 372900 ＜4057＞Infactory 530 80 51600
No Data
No Data